Screener
Medtronic MDT Impairment Charges
Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions) | Fiscal Year / 2026 | Fiscal Year / 2025 | Fiscal Year / 2024 |
|---|---|---|---|
| Provision for credit losses | 136 | 123 | 90 |
| Deferred income taxes | 51 | (316) | (508) |
| Stock-based compensation | 457 | 429 | 393 |
| Asset impairments and related inventory write-downs | — | — | 371 |
| Other, net | 314 | 310 | 573 |
| Change in operating assets and liabilities, net of acquisitions and divestitures: | |||
| Accounts receivable, net | (200) | (433) | (391) |
| Inventories | (404) | (292) | (139) |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's impairment charges?
- Medtronic (MDT) reported impairment charges of $0 in Q1 2026.
- What is the long-term trend for Medtronic's impairment charges?
- Over 4 years (2022 to 2026), Medtronic's impairment charges has grown at a -100.0% compound annual growth rate (CAGR), from $515M to $0.
- What does impairment charges mean?
- Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.
Ask your AI about Medtronic's impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude